AstraZeneca PLC (AZN)

AstraZeneca Revenue

AstraZeneca had revenue of $47.61B in the twelve months ending March 31, 2024, with 8.60% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $12.68B with 16.55% year-over-year growth. In the year 2023, AstraZeneca had annual revenue of $45.81B with 3.29% growth.

• Revenue (ttm): $47.61B
• Revenue Growth: +8.60%
• P/S Ratio: 5.02
• Revenue / Employee: $529,600
• Employees: 89,900
• Market Cap: 239.08B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	45.81B	1.46B	3.29%
Dec 31, 2022	44.35B	6.93B	18.53%
Dec 31, 2021	37.42B	10.80B	40.58%
Dec 31, 2020	26.62B	2.23B	9.16%
Dec 31, 2019	24.38B	2.29B	10.38%
Dec 31, 2018	22.09B	-375.00M	-1.67%
Dec 31, 2017	22.47B	-537.00M	-2.33%
Dec 31, 2016	23.00B	-1.71B	-6.90%
Dec 31, 2015	24.71B	-1.84B	-6.93%
Dec 31, 2014	26.55B	741.00M	2.87%
Dec 31, 2013	25.81B	-2.17B	-7.75%
Dec 31, 2012	27.97B	-5.62B	-16.72%
Dec 31, 2011	33.59B	322.00M	0.97%
Dec 31, 2010	33.27B	465.00M	1.42%
Dec 31, 2009	32.80B	1.20B	3.81%
Dec 31, 2008	31.60B	2.04B	6.91%
Dec 31, 2007	29.56B	3.08B	11.65%
Dec 31, 2006	26.48B	2.53B	10.54%
Dec 31, 2005	23.95B	2.52B	11.78%
Dec 31, 2004	21.43B	2.58B	13.67%
Dec 31, 2003	18.85B	1.01B	5.65%
Dec 31, 2002	17.84B	-	-
Dec 31, 2001	-	-	-
Dec 31, 2000	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.